Regenerative Medicine as a Disrupter in Clinical Trials
PharmaTalkRadio30 Jul 2019

Regenerative Medicine as a Disrupter in Clinical Trials

This is a keynote session from DPharm 2018. Dr Atala, a renowned key opinion leader on the topic of regenerative medicine, brings the DPharm audience a fascinating presentation on how it's possible to reduce the number of patients needed in clinical trials with the advancement of regenerative medicine, and how regenerative medicine can improve accuracy and speed up the clinical trial process. Speaker: Anthony Atala, MD, Director, Wake Forest Institute for Regenerative Medicine The 9th annual DPharm conference will take place on September 17-18, 2019 in Boston, MA. Learn more at theconferenceforum.org.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rekommandert
jss
sinnsyn
liberal-halvtime
forskningno
tomprat-med-gunnar-tjomlid
fjellsportpodden
rss-overskuddsliv
villmarksliv
dekodet-2
rss-paradigmepodden
rss-inn-til-kjernen-med-sunniva-rose
rss-zahid-ali-hjelper-deg
kvinnehelsepodden
rss-rekommandert
hva-er-greia-med
nevropodden
aldring-og-helse-podden